ESSA PHARMA INC's ticker is EPIX and the CUSIP is 29668H708. A total of 76 filers reported holding ESSA PHARMA INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $229,310 | -36.4% | 43,595 | +2.6% | 0.00% | – |
| Q1 2024 | $360,783 | -4.9% | 42,495 | -26.1% | 0.00% | – |
| Q4 2023 | $379,276 | +465.8% | 57,466 | +164.9% | 0.00% | – |
| Q3 2023 | $67,038 | +72.4% | 21,695 | +50.6% | 0.00% | – |
| Q2 2023 | $38,894 | +38.9% | 14,405 | +52.8% | 0.00% | – |
| Q1 2023 | $28,004 | +640.8% | 9,429 | +528.6% | 0.00% | – |
| Q4 2022 | $3,780 | -99.9% | 1,500 | +89.4% | 0.00% | – |
| Q1 2022 | $4,895,000 | +515.7% | 792 | +1314.3% | 0.00% | – |
| Q4 2021 | $795,000 | -78.1% | 56 | -87.6% | 0.00% | – |
| Q3 2021 | $3,624,000 | -70.6% | 453 | +5.1% | 0.00% | – |
| Q2 2021 | $12,314,000 | – | 431 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Soleus Capital Management, L.P. | 3,525,457 | $50,061,000 | 5.01% |
| MPM BioImpact LLC | 668,688 | $9,495,000 | 1.73% |
| BVF INC/IL | 2,851,461 | $40,491,000 | 1.47% |
| Altium Capital Management LP | 345,000 | $4,899,000 | 1.35% |
| Logos Global Management LP | 865,000 | $12,283,000 | 1.27% |
| Lynwood Capital Management Inc. | 57,181 | $812,000 | 0.78% |
| Avidity Partners Management LP | 2,460,000 | $34,932,000 | 0.74% |
| Bellevue Group AG | 5,034,814 | $71,495,000 | 0.74% |
| SPHERA FUNDS MANAGEMENT LTD. | 422,461 | $5,999,000 | 0.66% |
| Omega Fund Management, LLC | 328,196 | $4,660,000 | 0.66% |